JP2022538084A5 - - Google Patents
Info
- Publication number
- JP2022538084A5 JP2022538084A5 JP2021576279A JP2021576279A JP2022538084A5 JP 2022538084 A5 JP2022538084 A5 JP 2022538084A5 JP 2021576279 A JP2021576279 A JP 2021576279A JP 2021576279 A JP2021576279 A JP 2021576279A JP 2022538084 A5 JP2022538084 A5 JP 2022538084A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- gene
- library
- reagents
- modulating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962865047P | 2019-06-21 | 2019-06-21 | |
| US62/865,047 | 2019-06-21 | ||
| PCT/US2020/038503 WO2020257504A1 (en) | 2019-06-21 | 2020-06-18 | A genetic pharmacopeia for comprehensive functional profiling of human cancers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022538084A JP2022538084A (ja) | 2022-08-31 |
| JP2022538084A5 true JP2022538084A5 (enExample) | 2023-06-27 |
Family
ID=74040921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021576279A Pending JP2022538084A (ja) | 2019-06-21 | 2020-06-18 | ヒトの癌を対象とする包括的な機能プロファイリングのための遺伝子薬種 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220244244A1 (enExample) |
| EP (1) | EP3987087A4 (enExample) |
| JP (1) | JP2022538084A (enExample) |
| KR (1) | KR20220052902A (enExample) |
| CN (1) | CN114450440A (enExample) |
| AU (1) | AU2020294772A1 (enExample) |
| CA (1) | CA3144356A1 (enExample) |
| WO (1) | WO2020257504A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3443081A4 (en) | 2016-04-13 | 2019-10-30 | Duke University | CRISPR / CAS9-BASED REPRESSORS FOR IN VIVO SHUT-OFF OF GEN-TARGETS AND METHOD OF USE |
| US12509492B2 (en) | 2018-01-19 | 2025-12-30 | Duke University | Genome engineering with CRISPR-Cas systems in eukaryotes |
| CA3110837A1 (en) | 2018-08-28 | 2020-03-05 | Vor Biopharma Inc. | Genetically engineered hematopoietic stem cells and uses thereof |
| TWI887234B (zh) | 2019-04-14 | 2025-06-21 | 美國公爵大學 | 治療杜興氏（ｄｕｃｈｅｎｎｅ）肌肉失養症之大型突變熱點之ａａｖ載體介導之刪除 |
| WO2022056489A1 (en) * | 2020-09-14 | 2022-03-17 | Vor Biopharma, Inc. | Compositions and methods for cd38 modification |
| WO2022072643A1 (en) * | 2020-09-30 | 2022-04-07 | Vor Biopharma Inc. | Compositions and methods for cd30 gene modification |
| US11802866B2 (en) * | 2021-07-08 | 2023-10-31 | Medic Life Sciences Inc. | High-throughput screening system for identification of novel drugs and drug targets |
| IL310118A (en) * | 2021-07-16 | 2024-03-01 | Orthobio Therapeutics Inc | Gene editing to improve joint function |
| WO2023081200A2 (en) * | 2021-11-03 | 2023-05-11 | Intellia Therapeutics, Inc. | Cd38 compositions and methods for immunotherapy |
| CN114703191A (zh) * | 2022-04-19 | 2022-07-05 | 华南农业大学 | 基于crsipr技术构建rictor基因敲除细胞株的方法及其应用 |
| US20260234583A1 (en) * | 2023-02-10 | 2026-08-13 | Integrate Bioscience Llc | Personalized crispr profiling for cancer |
| WO2024220947A2 (en) * | 2023-04-21 | 2024-10-24 | Duke University | Epigenetic targets for enhancing cancer immunotherapy |
| EP4782540A1 (en) * | 2023-09-19 | 2026-07-29 | National University Corporation Tokai National Higher Education And Research System | Single-stranded polynucleotide |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007109527A1 (en) * | 2006-03-17 | 2007-09-27 | Bristol-Myers Squibb Company | Methods of identifying and treating individuals exhibiting mutant bcr/abl kinase polypeptides |
| WO2015065964A1 (en) * | 2013-10-28 | 2015-05-07 | The Broad Institute Inc. | Functional genomics using crispr-cas systems, compositions, methods, screens and applications thereof |
-
2020
- 2020-06-18 CA CA3144356A patent/CA3144356A1/en active Pending
- 2020-06-18 WO PCT/US2020/038503 patent/WO2020257504A1/en not_active Ceased
- 2020-06-18 EP EP20827723.6A patent/EP3987087A4/en active Pending
- 2020-06-18 US US17/619,563 patent/US20220244244A1/en active Pending
- 2020-06-18 CN CN202080059227.7A patent/CN114450440A/zh active Pending
- 2020-06-18 KR KR1020227001542A patent/KR20220052902A/ko not_active Ceased
- 2020-06-18 AU AU2020294772A patent/AU2020294772A1/en active Pending
- 2020-06-18 JP JP2021576279A patent/JP2022538084A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Amero et al. | Conversion of RNA aptamer into modified DNA aptamers provides for prolonged stability and enhanced antitumor activity | |
| Mathews et al. | Adenovirus virus-associated RNA and translation control | |
| Ivashchenko et al. | How miRNAs can protect humans from coronaviruses COVID-19, SARS-CoV, and MERS-CoV | |
| CN114042160B (zh) | Ctd-2256p15.2及其编码微肽作为靶点在开发肿瘤治疗药物中的应用 | |
| Gao et al. | BZW2 gene knockdown induces cell growth inhibition, G1 arrest and apoptosis in muscle‐invasive bladder cancers: A microarray pathway analysis | |
| KR20200044695A (ko) | Syt11 억제제를 유효성분으로 포함하는 위암 치료용 조성물 | |
| Lv et al. | Cofilin acts as a booster for progression of malignant tumors represented by glioma | |
| Dai et al. | Single-stranded RNA origami-based epigenetic immunomodulation | |
| CN119380801A (zh) | 一种基于trim56和sting的计算机辅助药物筛选方法、系统及设备 | |
| Yuan et al. | Newcastle disease virus activates methylation-related enzymes to reprogram m6A methylation in infected cells | |
| Yang et al. | OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumours | |
| CN109022461A (zh) | 一种PTEN基因的上游开放阅读框45aa-uORF核苷酸序列及其编码的多肽的应用 | |
| JP6286050B2 (ja) | トリインフルエンザウイルスのｍｉＲＮＡとその同定、検出および使用 | |
| CN112522267A (zh) | 长链非编码rna在调控结直肠癌5-fu耐药的应用 | |
| JP2024529939A5 (enExample) | ||
| Ren et al. | Comparative transcriptome analysis of long non coding RNA (lncRNA) in RTG-2 cells infected by infectious hematopoietic necrosis virus | |
| Yun et al. | Single-cell transcriptional profiling reveals cell type-specific responses to duck reovirus infection in the Bursa of Fabricius of Cairna moschata | |
| CN109562121A (zh) | 转移性癌症的诊断和治疗方法 | |
| CN105907757A (zh) | Linc00052基因的用途及其相关药物 | |
| Wang et al. | The σNS protein of NDRV antagonizes TRIM59-mediated antiviral innate immune response of Cherry Valley duck | |
| KR20260069622A (ko) | microRNA-유래 RNA 및 폴리펩타이드 및 이의 용도 | |
| Xu et al. | Integrated transcriptomic and metabolomic analysis identifies host response mechanisms to oncogenic Marek’s disease virus in Wenchang chickens | |
| CN111139299B (zh) | Josd2蛋白在制备治疗恶性肿瘤药物中的应用 | |
| Uhlmann et al. | Influence of osteopontin expression on the metastatic growth of CC531 rat colorectal carcinoma cells in rat liver | |
| Hoque et al. | Design of potential siRNA molecules for T antigen gene silencing of Merkel Cell Polyomavirus |